Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial

Isao Sakaida, Seiji Kawazoe, Kozo Kajimura, +5

Hepatology Research

Course and outcome of tubulointerstitial nephritis and uveitis syndrome

Tsukasa Takemura, Mitsuru Okada, Satoshi Hino, +5

American Journal of Kidney Diseases

Glomerular DiseaseGlomerulonephritisUrologyUveitis SyndromeNephritic Syndrome +3

Adipose Tissue–Specific Regulation of Angiotensinogen in Obese Humans and Mice: Impact of Nutritional Status and Adipocyte Hypertrophy

Shintaro Yasue, Hiroaki Masuzaki, Sadanori Okada, +17

American Journal of Hypertension

Skp2 Controls Adipocyte Proliferation during the Development of Obesity

Tamon Sakai, Hiroshi Sakaue, Takehiro Nakamura, +7

Journal of Biological Chemistry

Clinical and radiological features in four adolescents with nutcracker syndrome

T Takemura, H. Iwasa, Seiichiro Yamamoto, +5

Pediatric Nephrology

Nutcracker SyndromePediatricsGastroenterologyPediatric GastroenterologyPediatric Endocrinology +1

Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome

H Hirai, Mitsuru Okada, Hajime Mizoguchi, +4

Blood

Dose‐finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double‐blind, placebo‐controlled trial

Kiwamu Okita, Seiji Kawazoe, Chitomi Hasebe, +4

Hepatology Research

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

Kiwamu Okita, Isao Sakaida, Mitsuru Okada, +6

Journal of Gastroenterology

HepatologyMedicineLiver PhysiologyGastroenterologyPharmacotherapy +8

Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema

Isao Sakaida, Satoyoshi Yamashita, Tomoo Kobayashi, +5

Journal of International Medical Research

Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post‐marketing surveillance of tolvaptan in liver cirrhosis (START study)

Isao Sakaida, Shuji Terai, Masayuki Kurosaki, +4

Hepatology Research